Latest Impairment News

NRW Holdings faces a significant threat to its $113.3 million secured debt after the South Australian Government proposed legislation that could invalidate key lease agreements underpinning its security interests in Whyalla Ports.

Aristocrat Leisure reported solid half-year results with a 5.6% rise in normalised net profit after tax and before amortisation to $733 million, underpinned by growth across its gaming and interactive segments. The company also declared an unfranked interim dividend of 44 cents per share.

News Corporation has updated its financial statements to reflect the sale of Foxtel, reporting a 3% revenue increase in fiscal 2024 driven by its Digital Real Estate Services and Book Publishing segments, alongside a 66% rise in net income from continuing operations.

Commonwealth Bank of Australia reported a stable $2.6 billion cash profit for the quarter, maintaining strong capital and dividend payouts despite slight increases in consumer arrears and corporate credit risks.

Clean Seas Seafood Limited has entered a binding scheme of arrangement with Yumbah Aquaculture, offering shareholders a 52% premium cash exit or a speculative scrip alternative. The Independent Board Committee recommends approval, with a shareholder meeting set for June 23.

Marimaca Copper Corp reported a net loss of $2.25 million for Q1 2025, maintaining solid liquidity while managing risks tied to a significant receivable under liquidation proceedings.

Paladin Energy reports a 17% rise in quarterly uranium production and US$61 million in revenue, while recognizing a US$19.9 million inventory impairment. The company maintains strong liquidity and advances key projects in Namibia and Canada.

TasFoods reported a $10.7 million net loss for FY2024, challenged by an oversupplied poultry market and a significant asset impairment. The company is pivoting towards growth in pet treats and dairy exports to stabilize its future.

Dyno Nobel Limited reported a mixed half-year performance with a modest dip in revenues but a significant rise in net profit from continuing operations. The company is accelerating its transformation through major asset sales and a recommencement of its substantial share buyback program.

Macquarie Group Limited reported a 5% increase in net profit to A$3.715 billion for FY2025, driven by growth in asset management and banking segments alongside a robust capital and liquidity position.

Macquarie Group reported a 5% rise in full-year net profit to A$3.715 billion for FY25, driven by growth across its diversified businesses and a solid capital position. The group’s assets under management reached A$941 billion, supported by strong home loan and deposit growth.

Nyrada’s experimental drug NYR-BI03 shows promising cardioprotective and anti-arrhythmic effects in animal models, reinforcing its potential as a treatment for acute myocardial infarction.